Paper36764320
Global reporting of progress towards elimination of hepatitis B and hepatitis C.
Cui F and 20 others. Lancet Gastroenterol Hepatol, 2023. Cited by 271 papers, by iCite.
Cite this record
ConductScience Library. Global reporting of progress towards elimination of hepatitis B and hepatitis C. Papers, record 36764320. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36764320
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis B, Chronic | Major topic |
| Hepatitis C, Chronic | Major topic |
| Hepatitis C | Major topic |
| Hepatitis B | Major topic |
| Hepatitis, Viral, Human | Major topic |
| Hepatitis A | Major topic |
| Humans | |
| Antiviral Agents | |
| Hepacivirus |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 001 | World Health Organization | International | PubMed | |
| MR/R015600/1 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 36764321 | Strategic information to guide elimination of viral hepatitis. | https://conductscience.org/library/papers/36764321 |
Source PubMed
Cited by191
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 271 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42983274 | Influence mechanism of social norms on prescribing behavior for chronic hepatitis B and its variation between different prescriber subgroups. | BMC Prim Care | 2026 | https://conductscience.org/library/papers/42983274 | PubMed |
| 42977965 | Association between awareness of government notification and 'negative hepatitis virus test result card' and implementation of hepatitis B and C screening in Japanese workplaces: a cross-sectional study. | BMC Public Health | 2026 | https://conductscience.org/library/papers/42977965 | PubMed |
| 42959244 | The hidden burden of viral hepatitis B and C in healthcare settings: a cross-sectional study of seroprevalence, predictors, and occult infection. | Front Public Health | 2026 | https://conductscience.org/library/papers/42959244 | PubMed |
| 42934603 | Communicating hepatitis B: a content, readability and suitability assessment of Australian hepatitis B patient resources. | BMC Public Health | 2026 | https://conductscience.org/library/papers/42934603 | PubMed |
| 42882394 | Clinical Performance of the Elecsys HCV Duo Immunoassay Compared with a Standard-of-Care Algorithm Using Alinity Anti-HCV Screening and HCV RNA Confirmation. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42882394 | PubMed |
| 42797761 | Emergency Department-Based Screening and Linkage-to-Care for Hepatitis B, C, and D in a Referral Hospital in Barcelona, Spain: Reduction in Hepatitis C Prevalence After Five Years. | Viruses | 2026 | https://conductscience.org/library/papers/42797761 | PubMed |
| 42741255 | Trends and forecasting of reported hepatitis B and hepatitis C incidence in Hainan Province, China, 2005-2020. | Front Epidemiol | 2026 | https://conductscience.org/library/papers/42741255 | PubMed |
| 42703992 | Machine Learning Model for Predicting Hepatocellular Carcinoma Development in Patients With Hepatitis B Virus-Related Cirrhosis Receiving Antiviral Therapy. | Kaohsiung J Med Sci | 2026 | https://conductscience.org/library/papers/42703992 | PubMed |
| 42668088 | Hepatitis B Surface Antigen Directly Alters Dendritic Cell-Mediated Natural Killer Cell Responses. | Cell Mol Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/42668088 | PubMed |
| 42655715 | Unraveling HBV Life Cycle by Fluorescent Microscopy Imaging. | Viruses | 2026 | https://conductscience.org/library/papers/42655715 | PubMed |
| 42554489 | Rapid, low-cost, and portable molecular detection of HIV-1 subtype B and HCV 1a directly from blood. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/42554489 | PubMed |
| 42483732 | Chronic Hepatitis B in the Asia-Pacific Region: Results of the 2023 Global Burden of Disease Study. | J Clin Transl Hepatol | 2026 | https://conductscience.org/library/papers/42483732 | PubMed |
| 42458322 | Spatiotemporal epidemiology of hepatitis B in Central China: urbanization drivers and implications for adult-targeted control strategies. | BMC Public Health | 2026 | https://conductscience.org/library/papers/42458322 | PubMed |
| 42414971 | Development and validation of a machine learning model for evidence of prior or current HCV infection: a demographic screening approach for the US population. | BMC Public Health | 2026 | https://conductscience.org/library/papers/42414971 | PubMed |
| 42393060 | Projected health benefits and cost offsets from the United States National Hepatitis C Elimination Initiative. | Nat Commun | 2026 | https://conductscience.org/library/papers/42393060 | PubMed |
| 42381729 | Noninvasive Prediction of Significant Hepatic Injury in Treatment-Naïve Children with Chronic HBV Infection. | Infect Drug Resist | 2026 | https://conductscience.org/library/papers/42381729 | PubMed |
| 42352282 | Natural Alkaloids Against Liver Injury: Mechanistic Insights and Multi-Target Therapeutic Potential. | Biomolecules | 2026 | https://conductscience.org/library/papers/42352282 | PubMed |
| 42328238 | Expert Consensus on the Prevention and Treatment of Chronic Hepatitis B in Children. | Infect Dis Immun | 2024 | https://conductscience.org/library/papers/42328238 | PubMed |
| 42325858 | Epidemiology, natural history, and outcome of chronic hepatitis B in children. | Infect Dis Immun | 2025 | https://conductscience.org/library/papers/42325858 | PubMed |
| 42292767 | Modeling Highlights the Challenge of Achieving and Maintaining Hepatitis C Virus Micro-Elimination Among People Who Inject Drugs. | Open Forum Infect Dis | 2026 | https://conductscience.org/library/papers/42292767 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36764320
GET https://conductscience.org/api/papers/v1/36764320/authors?page=2